Clinical Trial Update: Mycophenolate Mofetil in Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mycophenolate mofetil for myasthenia gravis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Myasthenia Gravis | Phase 3 | Status: COMPLETED